| Item | Current | Prior | YoY % |
|---|---|---|---|
| Net Sales | ¥40.87B | ¥35.09B | +16.5% |
| Cost of Sales | ¥36.07B | ¥30.96B | +16.5% |
| Gross Profit | ¥4.80B | ¥4.13B | +16.0% |
| SG&A Expenses | ¥3.57B | ¥2.93B | +21.7% |
| Operating Income | ¥1.23B | ¥1.20B | +2.1% |
| Non-operating Income | ¥249M | ¥157M | +59.4% |
| Non-operating Expenses | ¥106M | ¥83M | +27.9% |
| Ordinary Income | ¥1.37B | ¥1.28B | +7.4% |
| Profit Before Tax | ¥1.52B | ¥1.57B | -3.2% |
| Income Tax Expense | ¥537M | ¥540M | -0.4% |
| Net Income | ¥982M | ¥1.03B | -4.6% |
| Net Income Attributable to Owners | ¥946M | ¥999M | -5.3% |
| Total Comprehensive Income | ¥1.12B | ¥929M | +20.6% |
| Interest Expense | ¥74M | ¥45M | +66.4% |
| Earnings per Unit (EPU) | ¥251.57 | ¥265.78 | -5.3% |
| Distribution per Unit (DPU) | ¥25.00 | ¥25.00 | +0.0% |
| Item | Current End | Prior End | Change |
|---|---|---|---|
| Current Assets | ¥19.73B | ¥17.97B | +¥1.77B |
| Cash and Deposits | ¥7.38B | ¥6.77B | +¥615M |
| Accounts Receivable | ¥8.24B | ¥7.48B | +¥760M |
| Inventories | ¥2.41B | ¥2.22B | +¥195M |
| Non-current Assets | ¥17.90B | ¥16.27B | +¥1.63B |
| Item | Value |
|---|---|
| Net Profit Margin | 2.3% |
| Gross Profit Margin | 11.7% |
| Current Ratio | 153.1% |
| Quick Ratio | 134.4% |
| Debt-to-Equity Ratio | 1.43x |
| Interest Coverage Ratio | 16.57x |
| Effective Tax Rate | 35.4% |
| Item | YoY Change |
|---|---|
| Net Sales YoY Change | +16.5% |
| Operating Income YoY Change | +2.1% |
| Ordinary Income YoY Change | +7.4% |
| Net Income Attributable to Owners YoY Change | -5.2% |
| Total Comprehensive Income YoY Change | +20.5% |
| Item | Value |
|---|---|
| Units Outstanding (incl. Treasury) | 3.77M shares |
| Treasury Units | 4K shares |
| Average Units Outstanding | 3.76M shares |
| NAV per Unit | ¥4,107.14 |
| Item | Amount |
|---|---|
| Q2 Distribution | ¥25.00 |
| Year-End Distribution | ¥40.00 |
| Segment | Revenue | Operating Income |
|---|---|---|
| DispensingPharmacy | ¥19.61B | ¥989M |
| HealthCare | ¥6.71B | ¥84M |
| MedicalProductsWholesale | ¥15.21B | ¥163M |
| RealEstate | ¥196M | ¥107M |
| Item | Forecast |
|---|---|
| Net Sales Forecast | ¥53.00B |
| Operating Income Forecast | ¥1.60B |
| Ordinary Income Forecast | ¥1.80B |
| Net Income Attributable to Owners Forecast | ¥1.25B |
| Earnings per Unit Forecast (EPU) | ¥332.07 |
| Distribution per Unit Forecast (DPU) | ¥60.00 |
| Property, Plant & Equipment | ¥10.93B | ¥10.04B | +¥886M |
| Intangible Assets | ¥980M | ¥990M | ¥-10M |
| Goodwill | ¥806M | ¥816M | ¥-10M |
| Investment Securities | ¥2.59B | ¥2.41B | +¥182M |
| Total Assets | ¥37.63B | ¥34.23B | +¥3.40B |
| Current Liabilities | ¥12.89B | ¥11.67B | +¥1.22B |
| Accounts Payable | ¥6.13B | ¥5.44B | +¥688M |
| Short-term Loans | ¥1.48B | ¥1.18B | +¥300M |
| Non-current Liabilities | ¥9.27B | ¥7.85B | +¥1.42B |
| Long-term Loans | ¥6.99B | ¥6.05B | +¥941M |
| Total Liabilities | ¥22.16B | ¥19.52B | +¥2.64B |
| Total Equity | ¥15.47B | ¥14.71B | +¥755M |
| Capital Stock | ¥917M | ¥917M | ¥0 |
| Capital Surplus | ¥1.06B | ¥1.09B | ¥-21M |
| Retained Earnings | ¥12.47B | ¥12.39B | +¥77M |
| Treasury Stock | ¥-7M | ¥-532M | +¥525M |
| Owners' Equity | ¥14.82B | ¥14.10B | +¥720M |
| Working Capital | ¥6.84B | - | - |